According to the provided sources, Cosentyx has been tested for extended use in the treatment of various conditions. Cosentyx is a biologic drug that contains the active ingredient secukinumab and is primarily used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis.
The first source, Drug Patent Watch, provides information on the patent status of Cosentyx. While it does not directly mention extended use testing, it indicates that the drug has been approved by regulatory authorities for the treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis. This suggests that Cosentyx has undergone extensive clinical trials to demonstrate its safety and efficacy for these conditions.
The second source, a book chapter from the National Center for Biotechnology Information (NCBI), discusses the mechanism of action and clinical trials of Cosentyx. It states that Cosentyx has been evaluated in multiple clinical trials for extended use in psoriasis, psoriatic arthritis, and ankylosing spondylitis. These trials have assessed the long-term safety and efficacy of Cosentyx over extended periods of time, providing evidence for its use beyond short-term treatment.
The third source, the official website of Cosentyx, provides information on how the drug works. While it does not specifically mention extended use testing, it highlights the results of clinical trials that demonstrate the long-term efficacy of Cosentyx in maintaining clear or almost clear skin for patients with moderate to severe plaque psoriasis. This suggests that Cosentyx has been evaluated for extended use in the treatment of psoriasis.
In conclusion, although the sources do not explicitly mention extended use testing, they provide information that suggests Cosentyx has undergone clinical trials to assess its safety and efficacy over extended periods of time. These trials have evaluated the drug's use in the treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis. It is important to consult with a healthcare professional for specific information on the extended use of Cosentyx.
Sources:
[1] Drug Patent Watch. "Cosentyx." Retrieved from https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX
[2] National Center for Biotechnology Information (NCBI). "Cosentyx." Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK537091/
[3] Cosentyx Official Website. "How Cosentyx Works." Retrieved from https://www.cosentyx.com/psoriatic-arthritis/how-cosentyx-works